Soleno Therapeutics (SLNO) Change in Acquisitions & Divestments (2024 - 2026)

Soleno Therapeutics (SLNO) has 3 years of Change in Acquisitions & Divestments data on file, last reported at $139.3 million in Q1 2026.

• Change in Acquisitions & Divestments for Q1 2026 came in at $139.3 million, up 103.94% year-over-year; the trailing twelve-month figure through Mar 2026 was $325.1 million (up 63.1% YoY), and the FY2025 annual result was $254.1 million, up 93.95% from the prior year.
• Change in Acquisitions & Divestments advanced to $139.3 million in Q1 2026 per SLNO's latest filing, from $62.5 million in the prior quarter.
• Over five years, Change in Acquisitions & Divestments peaked at $139.3 million in Q1 2026 and troughed at $25.0 million in Q2 2024.
• A 3-year average of $65.5 million and a median of $58.3 million in 2024 frame the typical range for Change in Acquisitions & Divestments.
• On a YoY basis, Change in Acquisitions & Divestments climbed as much as 106.0% in 2025 and fell as far as 15.81% in 2025.
• A 3-year view of Change in Acquisitions & Divestments shows it stood at $54.0 million in 2024, then gained by 15.81% to $62.5 million in 2025, then jumped by 122.73% to $139.3 million in 2026.
• Business Quant data shows SLNO's Change in Acquisitions & Divestments at $139.3 million in Q1 2026, $62.5 million in Q4 2025, and $71.7 million in Q3 2025.